Marinus Pharmaceuticals appoints Lorianne Masuoka as chief medical officer
The Pharma Letter | April 11, 2017
USA-based Marinus Pharmaceuticals (Nasdaq: MRNS), a biotech company focused on developing treatments for epilepsy and neuropsychiatric disorders, has appointed Lorianne Masuoka as chief medical officer.